Lindsey is Director of Marketing for the Small Molecule Therapeutics division within Prometic. As part of her responsibility for portfolio management, she is focused on identifying rare disease targets for Prometic’s pipeline products. Before joining Prometic, Lindsey worked as a marketing and business development consultant, with a focus on oncology, autoimmunity and immune therapeutics. She has held marketing and business development positions in several biotech companies including Cangene and Acambis (now part of Sanofi) and also worked as a management consultant with McKinsey & Company in London.
Lindsey studied Immunology at the University of Glasgow in Scotland. She also holds a PhD in leukemia research from the same institution.